dc.contributor.author | Simsekoglu, Muhammed Fatih | |
dc.contributor.author | Talat, Zubeyr | |
dc.contributor.author | Erozenci, Ahmet | |
dc.contributor.author | Uslu, Ezel | |
dc.contributor.author | ÇİTGEZ, Sinharib | |
dc.contributor.author | DEMİRDAĞ, Çetin | |
dc.contributor.author | ÖNAL, Bülent | |
dc.contributor.author | Kaleler, Islim | |
dc.date.accessioned | 2021-03-02T15:45:27Z | |
dc.date.available | 2021-03-02T15:45:27Z | |
dc.identifier.citation | Simsekoglu M. F. , Kaleler I., ÖNAL B., DEMİRDAĞ Ç., ÇİTGEZ S., Uslu E., Erozenci A., Talat Z., "Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021 | |
dc.identifier.issn | 1368-5031 | |
dc.identifier.other | av_e6eb5264-3582-4bd6-8e82-c0378266618e | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/1662 | |
dc.identifier.uri | https://doi.org/10.1111/ijcp.13959 | |
dc.description.abstract | Background Mast cells play a critical role in cancer-associated immunity. We aimed to determine the predictive value of urinary mast cell mediators in patients with non-muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG) immunotherapy. | |
dc.language.iso | eng | |
dc.subject | General Health Professions | |
dc.subject | Pathophysiology | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Pharmacology | |
dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
dc.subject | Family Practice | |
dc.subject | Pharmacology (medical) | |
dc.subject | Fundamentals and Skills | |
dc.subject | Medicine (miscellaneous) | |
dc.subject | General Medicine | |
dc.subject | Drug Guides | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | Pharmacy | |
dc.subject | Internal Medicine | |
dc.subject | Assessment and Diagnosis | |
dc.title | Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer? | |
dc.type | Makale | |
dc.relation.journal | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.contributor.firstauthorID | 2504197 | |